Addition Therapeutics
USEntry
2025
Hold
1yr
Status
Active
Who owns Addition Therapeutics?
Addition Therapeutics is currently owned by Abingworth through Abingworth Bioventures IX (2023 vintage), since 2025.
Hand-verified · updated 2026-07-08
More from Abingworth Bioventures IX
Other portfolio companies in the same fund.
More Abingworth portfolio companies
From the same investor, across funds.
UK
More PE-backed in Biotech
Comparable biotech deals from other GPs.
FranceTrack Addition Therapeutics
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Addition Therapeutics?
7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Addition Therapeutics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue